. . . . . . . . . "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." . . . . . . "Adults" . . . "2021-08-24T20:13:50.640391"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "F6PcR5J56A0r2WUq5Bt+W3zwKdEyn99Proh4djvGxPE1opq7kotapHBV3cKM8icV1RdZoeVBi6V8WateJ2bvZf5W7m4sx9Mz6VcVjS8PPf/sAKZlieYgN3joEdyhGvBdI6wfXA3MhrMmgMexKXYi3EDmzbORXRfgQPQHall1mDs=" . . "2021-08-24T20:13:50.640391"^^ . . .